Candesartan cilexetil and Hypercalcaemia - a phase IV clinical study of FDA data

Summary:

Hypercalcaemia is reported as a side effect among people who take Candesartan cilexetil (candesartan cilexetil), especially for people who are female, 60+ old, also take Ondansetron, and have Osteoporosis.

The phase IV clinical study analyzes which people have Hypercalcaemia when taking Candesartan cilexetil. It is created by eHealthMe based on reports of 14,487 people who have side effects when taking Candesartan cilexetil from the FDA, and is updated regularly.

What is Candesartan cilexetil?

Candesartan cilexetil has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 15,294 Candesartan cilexetil users. Check the latest studies of Candesartan cilexetil.

What is Hypercalcaemia?

Hypercalcaemia (elevated calcium (ca+) level in the blood) is found to be associated with 1,063 drugs and 1,017 conditions by eHealthMe. Check the latest studies of Hypercalcaemia.

On Jul, 15, 2026

14,487 people reported to have side effects when taking Candesartan cilexetil.
Among them, 25 people (0.17%) have Hypercalcaemia.

Could Candesartan cilexetil cause Hypercalcaemia?

Among these 25 people:

What is the gender of people who have Hypercalcaemia when taking Candesartan cilexetil? *

female: 75 %
male: 25 %

What is the age of people who have Hypercalcaemia when taking Candesartan cilexetil? *

What are other drugs people take besides Candesartan cilexetil? *

Prednisolone: 5 people, 20.00%
Ondansetron: 5 people, 20.00%
Zopiclone: 4 people, 16.00%
Levothyroxine Sodium: 4 people, 16.00%
Valacyclovir Hydrochloride: 3 people, 12.00%
Lyrica: 3 people, 12.00%
Lansoprazole: 3 people, 12.00%
Folic Acid: 3 people, 12.00%
Allopurinol: 3 people, 12.00%
Bactrim: 3 people, 12.00%

What are other side effects people have besides Hypercalcaemia? *

Acute Kidney Failure: 5 people, 20.00%
Anaemia (lack of blood): 5 people, 20.00%
Nausea (feeling of having an urge to vomit): 5 people, 20.00%
Dizziness: 5 people, 20.00%
Confusion: 4 people, 16.00%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 16.00%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 12.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 12.00%
Blepharitis (chronic inflammation of the eyelid): 3 people, 12.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 12.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 24.00%
Pain: 5 people, 20.00%
Gastritis (inflammation of stomach): 4 people, 16.00%
Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 4 people, 16.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 3 people, 12.00%
Drug Hypersensitivity: 3 people, 12.00%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 12.00%
Hypersensitivity: 3 people, 12.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 12.00%
Spinal Column Stenosis (narrowing of spinal column): 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Candesartan cilexetil and have Hypercalcaemia?

- Check whether Hypercalcaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Candesartan cilexetil:

Candesartan cilexetil (15,294 reports)

Hypercalcaemia treatments and more:

Hypercalcaemia (18,731 reports)

Browse all side effects of Candesartan cilexetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercalcaemia:

Hypercalcaemia (1,063 drugs)

Browse all the conditions that are associated with Hypercalcaemia:

Hypercalcaemia (1,017 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil (the active ingredients of Candesartan cilexetil) and Candesartan cilexetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.